People: Dendreon Corp (DNDN.O)
Ms. Christine Mikail Cvijic has been appointed as Executive Vice President - Corporate Development, General Counsel, Secretary of Dendreon Corp., effective February 28, 2012. Ms. Mikail previously served as Senior Vice President, Corporate Strategy and Corporate Development at Savient Pharmaceuticals, Inc., a specialty bio-pharmaceutical company, from February 2011 until February 2012. From March 2008 until February 2011, Ms. Mikail held several positions at both ImClone, a wholly-owned subsidiary of Eli Lilly and Company, and Eli Lilly and Company, and served as Vice President, General Counsel and Secretary of ImClone prior to her departure. Prior to that time, Ms. Mikail worked at the law firms of Reed Smith LLP from August 2005 until March 2008, Lowenstein Sandler PC from 2004 until 2005, and WilmerHale during 2001 and from 2002 until 2004. She earned her Bachelor of Arts from Rutgers University and J.D. from Fordham University School of Law.
|Total Annual Compensation, USD||Long-Term Incentive Plans, USD||All Other, USD||Fiscal Year Total, USD|